Introducing Shivom and the OmiX Token
Omix (OMX) is a digital asset built to utilize the Shivom genomics and healthcare platform, currently under development by the Shivom blockchain team, in partnership with Ocean and Spherity.
With dropping costs of sequencing technology, the ever-expanding capabilities of storing genomic data on a cloud, and the growing market size of the genomic health market, sequencing is within the grasp for many. But there’s currently an imbalance of power in the genomic sequencing market and the data handling practices associated with those companies. Only a few large players control the market, profit extensively from selling that data to pharma, without permission or incentivization for the data donor. The majority of the populations around the globe are underserved, hard to reach, and don’t benefit from these services, yet the genomic data of the few is powering the development of pharmaceuticals for the many.
Shivom has the capability to change the dynamics of this market. By utilizing novel technologies like blockchain, large data analytics, and AI, we’re pushing the boundaries to bring genomic sequencing and analysis to everyone on a global scale. We’re creating the largest genomic data hub, where everyone can be incentivized to upload, analyze and monetize their data, in order to power drug research and development by pharma and institutions. Beyond that, we are creating an unprecedented health care platform where layers of encryption will ensure that personal genomic and healthcare data remains private, secure, and only accessible to those the user desires to allow.
One of my cofounders is a PhD with 15+ years experience and 3 successful companies in the Genomics space. The other one is among the top 100 blockchain influencers with two top 100 blockchain companies. Our CMO is among the top 10 blockchain influencers and an advisor to Forbes and the UK Government. Our CIO is currently a venture partner at DraperDragon fund and was previously a partner at DFJ Dragon Fund and DragonVenture, as well as the founder of the Global Chamber San Francisco and a member of the Board of Advisors at multiple Silicon Valley tech companies.
We have recently signed a partnership with GTG Labs, a predictive testing and molecular diagnostics company that’s publicly traded on NASDAQ and the ASX. Through them, we have access to development of new genetic SNP panels, as well as US accredited laboratory facilities. Additionally, we have just signed a partnership with the Government of Andhra Pradesh in India to gain access to the sequencing of up to 60 million individuals, and will be initiating a pilot project at a major cancer facility shortly. More partnership announcements are subsequently on the way.
https://www.nasdaq.com/press-release/genetic-technologies-limited-project-shivom-strategic-alliance-20180306-00210
Our solution will create shared value for individuals, not-for-profit organizations, governments and for-profit entities alike, and in doing so, we can drive genomics and personalized medicine into a new era.
Our token sale offers the unique opportunity to participate in the healthcare revolution and purchase OMX tokens. With your participation we will dominate the global blockchain-based genomics market.
We have raised 42k ETH so far from several prominent funds such as Collinstar Capital, Hoperidge Capital, Springview Capital and DigitalX, as well as several family offices, HNW individuals and other influential people (for example a Member of the European Parliament). Also, we already have agreements in place to ensure OMX liquidity - including those with BTCAlpha and Bancor, with more on the way.
Join us on our exciting journey:
https://shivom.io/
https://t.me/projshivom
Omix (OMX) is a digital asset built to utilize the Shivom genomics and healthcare platform, currently under development by the Shivom blockchain team, in partnership with Ocean and Spherity.
With dropping costs of sequencing technology, the ever-expanding capabilities of storing genomic data on a cloud, and the growing market size of the genomic health market, sequencing is within the grasp for many. But there’s currently an imbalance of power in the genomic sequencing market and the data handling practices associated with those companies. Only a few large players control the market, profit extensively from selling that data to pharma, without permission or incentivization for the data donor. The majority of the populations around the globe are underserved, hard to reach, and don’t benefit from these services, yet the genomic data of the few is powering the development of pharmaceuticals for the many.
Shivom has the capability to change the dynamics of this market. By utilizing novel technologies like blockchain, large data analytics, and AI, we’re pushing the boundaries to bring genomic sequencing and analysis to everyone on a global scale. We’re creating the largest genomic data hub, where everyone can be incentivized to upload, analyze and monetize their data, in order to power drug research and development by pharma and institutions. Beyond that, we are creating an unprecedented health care platform where layers of encryption will ensure that personal genomic and healthcare data remains private, secure, and only accessible to those the user desires to allow.
One of my cofounders is a PhD with 15+ years experience and 3 successful companies in the Genomics space. The other one is among the top 100 blockchain influencers with two top 100 blockchain companies. Our CMO is among the top 10 blockchain influencers and an advisor to Forbes and the UK Government. Our CIO is currently a venture partner at DraperDragon fund and was previously a partner at DFJ Dragon Fund and DragonVenture, as well as the founder of the Global Chamber San Francisco and a member of the Board of Advisors at multiple Silicon Valley tech companies.
We have recently signed a partnership with GTG Labs, a predictive testing and molecular diagnostics company that’s publicly traded on NASDAQ and the ASX. Through them, we have access to development of new genetic SNP panels, as well as US accredited laboratory facilities. Additionally, we have just signed a partnership with the Government of Andhra Pradesh in India to gain access to the sequencing of up to 60 million individuals, and will be initiating a pilot project at a major cancer facility shortly. More partnership announcements are subsequently on the way.
https://www.nasdaq.com/press-release/genetic-technologies-limited-project-shivom-strategic-alliance-20180306-00210
Our solution will create shared value for individuals, not-for-profit organizations, governments and for-profit entities alike, and in doing so, we can drive genomics and personalized medicine into a new era.
Our token sale offers the unique opportunity to participate in the healthcare revolution and purchase OMX tokens. With your participation we will dominate the global blockchain-based genomics market.
We have raised 42k ETH so far from several prominent funds such as Collinstar Capital, Hoperidge Capital, Springview Capital and DigitalX, as well as several family offices, HNW individuals and other influential people (for example a Member of the European Parliament). Also, we already have agreements in place to ensure OMX liquidity - including those with BTCAlpha and Bancor, with more on the way.
Join us on our exciting journey:
https://shivom.io/
https://t.me/projshivom